These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12131563)

  • 21. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients.
    Maagaard A; Holberg-Petersen M; Kollberg G; Oldfors A; Sandvik L; Bruun JN
    Antivir Ther; 2006; 11(5):601-8. PubMed ID: 16964828
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial DNA decrease in subcutaneous adipose tissue of HIV-infected individuals with peripheral lipoatrophy.
    Shikuma CM; Hu N; Milne C; Yost F; Waslien C; Shimizu S; Shiramizu B
    AIDS; 2001 Sep; 15(14):1801-9. PubMed ID: 11579242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion.
    Petit C; Mathez D; Barthélémy C; Leste-Lasserre T; Naviaux RK; Sonigo P; Leibowitch J
    J Acquir Immune Defic Syndr; 2003 Aug; 33(4):461-9. PubMed ID: 12869834
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of nucleoside reverse transcriptase inhibitors on mitochondrial DNA and RNA in human skeletal muscle cells.
    Saitoh A; Haas RH; Naviaux RK; Salva NG; Wong JK; Spector SA
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2825-30. PubMed ID: 18541728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.
    Casula M; Weverling GJ; Wit FW; Timmermans EC; Stek M; Lange JM; Reiss P
    J Infect Dis; 2005 Nov; 192(10):1794-800. PubMed ID: 16235179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased mitochondrial DNA content in subcutaneous fat from HIV-infected women taking antiretroviral therapy as measured at delivery.
    Nasi M; Pinti M; Chiesa E; Fiore S; Manzini S; Del Giovane C; D'Amico R; Palai N; Campatelli C; Sabbatini F; Roccio M; Tibaldi C; Masuelli G; Mussini C; Ferrazzi E; d'Arminio Monforte A; Cossarizza A;
    Antivir Ther; 2011; 16(3):365-72. PubMed ID: 21555819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in the peripheral blood mtDNA levels in naive patients treated by different nucleoside reverse transcriptase inhibitor combinations and their association with subsequent lipodystrophy.
    Chêne G; Amellal B; Pédrono G; Gourlain K; Rancinan C; Journot V; Cotte L; Palmer P; Castro ND; Calvez V; Molina JM;
    AIDS Res Hum Retroviruses; 2007 Jan; 23(1):54-61. PubMed ID: 17263633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitors.
    Miller V; Stürmer M; Staszewski S; Gröschel B; Hertogs K; de Béthune MP; Pauwels R; Harrigan PR; Bloor S; Kemp SD; Larder BA
    AIDS; 1998 May; 12(7):705-12. PubMed ID: 9619801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.
    McComsey GA; Kang M; Ross AC; Lebrecht D; Livingston E; Melvin A; Hitti J; Cohn SE; Walker UA;
    HIV Clin Trials; 2008; 9(2):126-36. PubMed ID: 18474497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial evolution in HIV-infected children receiving first- or second-generation nucleoside analogues.
    Morén C; Noguera-Julian A; Garrabou G; Catalán M; Rovira N; Tobías E; Cardellach F; Miró Ò; Fortuny C
    J Acquir Immune Defic Syndr; 2012 Jun; 60(2):111-6. PubMed ID: 22362155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral blood mitochondrial DNA/nuclear DNA (mtDNA/nDNA) ratio as a marker of mitochondrial toxicities of stavudine containing antiretroviral therapy in HIV-infected Malawian patients.
    Kampira E; Dzobo K; Kumwenda J; van Oosterhout JJ; Parker MI; Dandara C
    OMICS; 2014 Jul; 18(7):438-45. PubMed ID: 24816082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.
    Carr A; Workman C; Smith DE; Hoy J; Hudson J; Doong N; Martin A; Amin J; Freund J; Law M; Cooper DA;
    JAMA; 2002 Jul; 288(2):207-15. PubMed ID: 12095385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA.
    Feeney ER; van Vonderen MG; Wit F; Danner SA; van Agtmael MA; Villarroya F; Domingo P; Capeau J; Reiss P; Mallon PW;
    AIDS; 2012 Nov; 26(17):2165-74. PubMed ID: 22874517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in mitochondrial DNA copy number in blood cells from HIV-infected patients undergoing antiretroviral therapy.
    de Mendoza C; de Ronde A; Smolders K; Blanco F; Garcia-Benayas T; de Baar M; Fernández-Casas P; González-Lahoz J; Soriano V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):271-3. PubMed ID: 15117449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection.
    Mallal SA; John M; Moore CB; James IR; McKinnon EJ
    AIDS; 2000 Jul; 14(10):1309-16. PubMed ID: 10930144
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uridine abrogates mitochondrial toxicity related to nucleoside analogue reverse transcriptase inhibitors in HepG2 cells.
    Walker UA; Venhoff N; Koch EC; Olschewski M; Schneider J; Setzer B
    Antivir Ther; 2003 Oct; 8(5):463-70. PubMed ID: 14640394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.
    Jones SP; Qazi N; Morelese J; Lebrecht D; Sutinen J; Yki-Jărvinen H; Back DJ; Pirmohamed M; Gazzard BG; Walker UA; Moyle GJ
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):565-72. PubMed ID: 16284533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial DNA levels in fat and blood cells from patients with lipodystrophy or peripheral neuropathy and the effect of 90 days of high-dose coenzyme Q treatment: a randomized, double-blind, placebo-controlled pilot study.
    Rabing Christensen E; Stegger M; Jensen-Fangel S; Laursen AL; Ostergaard L
    Clin Infect Dis; 2004 Nov; 39(9):1371-9. PubMed ID: 15494915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.